Global Intrauterine Devices Market Overview:
Global Intrauterine Devices Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Intrauterine Devices Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Intrauterine Devices involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Intrauterine Devices Market:
The Intrauterine Devices Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Intrauterine Devices Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Intrauterine Devices Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Intrauterine Devices market has been segmented into:
Hormonal Progestogen-Releasing IUD
Nonhormonal Copper-Containing IUD
By Application, Intrauterine Devices market has been segmented into:
15 - 24
25 - 34
35 - 44
Above 44
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Intrauterine Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Intrauterine Devices market.
Top Key Players Covered in Intrauterine Devices market are:
Allergan PLC
ANI Pharmaceuticals Inc.
Bayer AG
Besins Healthcare (Monaco)
CooperSurgical Inc.
Eurogine
S.L
HLL Lifecare Ltd.
HRA Pharma
OCON Medical Ltd.
Pregna International Ltd.
SMB Corporation
Teva Pharmaceutical Industries Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Intrauterine Devices Market Type
4.1 Intrauterine Devices Market Snapshot and Growth Engine
4.2 Intrauterine Devices Market Overview
4.3 Hormonal Progestogen-Releasing IUD
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Hormonal Progestogen-Releasing IUD: Geographic Segmentation Analysis
4.4 Nonhormonal Copper-Containing IUD
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Nonhormonal Copper-Containing IUD: Geographic Segmentation Analysis
Chapter 5: Intrauterine Devices Market Application
5.1 Intrauterine Devices Market Snapshot and Growth Engine
5.2 Intrauterine Devices Market Overview
5.3 15 - 24
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 15 - 24: Geographic Segmentation Analysis
5.4 25 - 34
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 25 - 34: Geographic Segmentation Analysis
5.5 35 - 44
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 35 - 44: Geographic Segmentation Analysis
5.6 Above 44
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Above 44: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Intrauterine Devices Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ALLERGAN PLC; ANI PHARMACEUTICALS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; BAYER AG; BESINS HEALTHCARE (MONACO); COOPERSURGICAL
6.4 INC.; EUROGINE
6.5 S.L; HLL LIFECARE LTD.; HRA PHARMA; OCON MEDICAL LTD.; PREGNA INTERNATIONAL LTD.; SMB CORPORATION; TEVA PHARMACEUTICAL INDUSTRIES LTD.
Chapter 7: Global Intrauterine Devices Market By Region
7.1 Overview
7.2. North America Intrauterine Devices Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Hormonal Progestogen-Releasing IUD
7.2.2.2 Nonhormonal Copper-Containing IUD
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 15 - 24
7.2.3.2 25 - 34
7.2.3.3 35 - 44
7.2.3.4 Above 44
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Intrauterine Devices Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Hormonal Progestogen-Releasing IUD
7.3.2.2 Nonhormonal Copper-Containing IUD
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 15 - 24
7.3.3.2 25 - 34
7.3.3.3 35 - 44
7.3.3.4 Above 44
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Intrauterine Devices Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Hormonal Progestogen-Releasing IUD
7.4.2.2 Nonhormonal Copper-Containing IUD
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 15 - 24
7.4.3.2 25 - 34
7.4.3.3 35 - 44
7.4.3.4 Above 44
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Intrauterine Devices Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Hormonal Progestogen-Releasing IUD
7.5.2.2 Nonhormonal Copper-Containing IUD
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 15 - 24
7.5.3.2 25 - 34
7.5.3.3 35 - 44
7.5.3.4 Above 44
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Intrauterine Devices Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Hormonal Progestogen-Releasing IUD
7.6.2.2 Nonhormonal Copper-Containing IUD
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 15 - 24
7.6.3.2 25 - 34
7.6.3.3 35 - 44
7.6.3.4 Above 44
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Intrauterine Devices Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Hormonal Progestogen-Releasing IUD
7.7.2.2 Nonhormonal Copper-Containing IUD
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 15 - 24
7.7.3.2 25 - 34
7.7.3.3 35 - 44
7.7.3.4 Above 44
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Intrauterine Devices Scope:
|
Report Data
|
Intrauterine Devices Market
|
|
Intrauterine Devices Market Size in 2025
|
USD XX million
|
|
Intrauterine Devices CAGR 2025 - 2032
|
XX%
|
|
Intrauterine Devices Base Year
|
2024
|
|
Intrauterine Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Allergan PLC, ANI Pharmaceuticals Inc., Bayer AG, Besins Healthcare (Monaco), CooperSurgical Inc., Eurogine, S.L, HLL Lifecare Ltd., HRA Pharma, OCON Medical Ltd., Pregna International Ltd., SMB Corporation, Teva Pharmaceutical Industries Ltd..
|
|
Key Segments
|
By Type
Hormonal Progestogen-Releasing IUD
Nonhormonal Copper-Containing IUD
By Applications
15 - 24
25 - 34
35 - 44
Above 44
|
